ArticleDermatology and therapy2022

Commentary on a Clinical Trial of Spesolimab, a Humanized Anti-interleukin-36 Receptor Monoclonal Antibody, in Generalized Pustular Psoriasis.

Shuai Shao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.